Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 November 1997

Sensitivity to antibiotics of Burkholderia (Pseudomonas) cepacia and Stenotrophomonas (Xanthomonas) maltophilia strains isolated from hospitalised patients

Eugenia Gospodarek, Iwona Kania, Małgorzata Białek

Med Sci Monit 1997; 3(6): BR807-812 :: ID: 501783

Abstract

Nosocomial infections are one of the biggest contemporary health and economic problems. Apart from the already known pathogens, several 'new' bacteria, such as Burkholderia cepacia and Stenotrophomonas maltophilia, etc, are now regarded as being responsible for nosocomial infections. This study aimed at evaluating the presence of Burkholderia cepacia and Stenotrophomonas maltophilia strains in diagnostic material and analysing their sensitivity to antibiotics. The study covered 47 strains of Burkholderia cepacia and 27 strains of Stenotrophomonas maltophilia, isolated from diagnostic materials sent to the Department of Medical Microbiology at the University School of Medical Science in Bydgoszcz in 1994-1995. Sensitivity to 15 antibiotics was evaluated by the circle diffusion method on Mueller-Hinton agar according to the procedure elaborated by NCCLS. Most Burkholderia cepacia strains (70.2%) were isolated from urine of patients with urinary tract infection. The basic disease suffered by these patients was usually a tumour of the urinary tract. Four (8.5%) strains of Burkholderia cepacia were isolated from purulent materials. Most strains (28, i.e. 59.6%) came from patients hospitalised on Urology Ward. Nine (19.2%) strains of Burkholderia cepacia came from Intensive Therapy patients. Forty three (91.5%) strains of Burkholderia cepacia were sensitive to co-trimoxazole and imipenem and 40 (85.1%) were sensitive to ceftazidime. Among the tested Burkholderia cepacia strains most of them were resistant to tobramycin and gentamycin (93.6%) and carbenicillin (87.2%). All strains were resistant to tetracycline. Among 27 strains defined as Stenotrophomonas maltophilia, 11 (40.7%) were isolated from wound smears and pus, 7 (25.9%) from secretion found in intubation tubes. Stenotrophomonas maltophilia strains were isolated from sample materials of patients hospitalised in 4 wards: 13 (48.2%) in Intensive Therapy, 5 (18.5%) on Neurology, 5 (18.5%) on Surgical Ward and 4 (14.8%) in Urology Ward. Tested Stenotrophomonas maltophilia strains were mostly sensitive to ticarcillin combined with clavulanic acid (23 strains, i.e. 85.2%), ciprofloxacin (21 strains, i.e. 77.8%), tobramycin (17 strains, i.e. 63.0%) and netilmycin (15 strains, i.e. 55.6%). Literature indicates that antibiotic therapy of Burkholderia cepacia and Stenotrophomonas maltophilia infections is difficult due to resistance of these micro-organisms to most antibiotics. Own results of sensitivity of these bacteria to antibiotics confirm their resistance to many antibiotics.

Keywords: Burkholderia cepacia, Stenotrophomonas maltophilia, resistance to antibiotics, nosocomial infections, Urinary Tract Infections

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750